Prognostic Value of the Pan-Immune Inflammatory Value and Fibrinogen-To-Albumin Ratio for Amputation in Patients With Lower Extremity Arterial Disease.
PIV and FAR were independently associated with amputation risk in patients with LEAD who underwent EVT and the addition of these biomarkers to established clinical variables provided incremental prognostic value and may offer additional prognostic information for risk stratification.